Peter E. Schwartz

297 papers receiving 13.3k citations

Peter E. Schwartz's Hit Papers

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis 2020 · 234 citations
2340+15+31Years since publication100200300400

Peers

Peter E. Schwartz
Comparison fields: 5 of 157
  • Reproductive Medicine 3.4k
  • Obstetrics and Gynecology 2.6k
  • Oncology 3.9k
  • Cancer Research 1.7k
  • Immunology 1.4k
Replace Takayuki Enomoto with:
Takayuki Enomoto Japan
Alessandro Davide Santin United States
Rainer Kimmig Germany
Sergio L. Pecorelli Italy
Hys Ngan Hong Kong
Ronald David Alvarez United States
Stephen C. Rubin United States
Neville F. Hacker Australia
Diane Michele Provencher Canada
Robert P. Edwards United States
Peter E. Schwartz relative to Takayuki Enomoto Japan Takayuki Enomoto's profile →
Citations per field
00.5×1.5×
Takayuki Enomoto · 1×
Citations per year

Countries citing papers authored by Peter E. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Peter E. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Schwartz more than expected).

Fields of papers citing papers by Peter E. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Schwartz. The network helps show where Peter E. Schwartz may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter E. Schwartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter E. Schwartz Line = papers co-authored together Peter E. Schwartz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 301 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography
Hit paper breakdown →
1979461
2 2009428
3
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Hit paper breakdown →
2018388
4 2008343
5 2013274
6 1990263
7 2008262
8 2000257
9 1986247
10
Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis
Hit paper breakdown →
2020234
11 1981222
12 1995209
13 2005202
14 1999197
15 2016180
16 2010151
17 1987147
18 2005146
19 2016145
20 1980136

About Peter E. Schwartz

Peter E. Schwartz is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Cancer Research and Genetics, having authored 301 papers that have together received 14.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (71 papers), HER2/EGFR in Cancer Research (35 papers), Endometrial and Cervical Cancer Treatments (25 papers), Estrogen and related hormone effects (14 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Cervical Cancer and HPV Research (13 papers), Intraperitoneal and Appendiceal Malignancies (10 papers) and Uterine Myomas and Treatments (10 papers). The work is most often cited by research in Reproductive Medicine (3.4k citations), Obstetrics and Gynecology (2.6k citations), Oncology (3.9k citations), Cancer Research (1.7k citations) and Immunology (1.4k citations). Peter E. Schwartz has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Thomas Rutherford, Joseph T. Chambers, Alessandro Davide Santin, Ernest I. Kohorn, Stefania Bellone, Mor Gil, Masoud Azodi, Dan‐Arin Silasi, Emiliano Cocco and Elena Ratner. Their work appears in journals such as Gynecologic Oncology, Cancer, American Journal of Obstetrics and Gynecology, International Journal of Gynecological Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact